EQ (Equillium) DeferredTaxAndRevenue: $0.00 Mil (As of Mar. 2026)


EQ Equillium Inc EQ
28 GF Score
Price $2.91
GF Value $0.10
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Equillium DeferredTaxAndRevenue?

Equillium EQ -1.69% 28 DeferredTaxAndRevenue is $0.00 Mil as of Mar. 2026. GuruFocus rates EQ with a GF Score™ of 28/100 and a GF Value™ of $0.10 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Equillium's current deferred tax and revenue for the quarter that ended in Mar. 2026 was $0.00 Mil.

Equillium DeferredTaxAndRevenue Related Terms

Equillium DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Equillium's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Equillium DeferredTaxAndRevenue Chart

Equillium Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only 0.00 14.70 15.73 0.00 0.00

Equillium Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
EQ
28GF Score
Equillium Inc EQ
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.00 Mil mean?
Equillium (EQ) has a DeferredTaxAndRevenue of $0.00 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Equillium.
Is Equillium's DeferredTaxAndRevenue too high?
Equillium's current DeferredTaxAndRevenue is $0.00 Mil. Overall, Equillium has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Equillium's DeferredTaxAndRevenue compare to ORMP and HUMA?
Equillium's DeferredTaxAndRevenue of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Biotechnology company?
A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Equillium. Equillium's current DeferredTaxAndRevenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Equillium stock overvalued right now?
Based on GuruFocus' analysis, Equillium (EQ) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.10, compared to a current price of $2.91 — trading 2810% above its estimated fair value. The current DeferredTaxAndRevenue is $0.00 Mil. Equillium's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Equillium (EQ), the current DeferredTaxAndRevenue is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Equillium (EQ) Overvalued in 2026?

Based on GuruFocus' analysis, Equillium stock appears to be overvalued. The current stock price of $2.91 is trading 2810% above its estimated GF Value™ of $0.10. GuruFocus considers Equillium to be Significantly Overvalued.

Key valuation signals for EQ:

  • DeferredTaxAndRevenue: $0.00 Mil
  • GF Value™: $0.10 vs. price of $2.91 (2810% above fair value)
  • GF Score™: 28/100 with 3 warning signs

No single metric tells the full story. See the EQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Equillium Business Description

Other Exchanges 0A4D:UK0FY:Germany
Address 2223 Avenida De La Playa, Suite 105, La Jolla, CA, USA, 92037
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
28GF Score

Get the complete analysis for EQ

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.91
Price
$0.10
GF Value